Showing 7621-7630 of 8194 results for "".
- Cipher Pharmaceuticals Acquires Innocutishttps://practicaldermatology.com/news/cipher-pharmaceuticals-acquires-innocutis/2458969/Cipher Pharmaceuticals Inc. has acquired Innocutis Holdings LLC, a privately held specialty dermatology company, for US$45.5 million in cash. (All financial references are in U.S. dollars unless otherwise noted.) "This acquisition marks our commercial entry to the U.S. market an
- CareCredit Hosts Free Webinar on How to Host Successful Patient Eventshttps://practicaldermatology.com/news/carecredit-hosts-free-webinar-on-how-to-host-successful-patients-events/2458975/CareCredit will be sponsoring a free webinar to all aesthetic providers on how to host successful patient events. The webinar, How to Host Events That Bring Real Results: The Dos, Don’ts, and Definites, will be presented by Karen Zupko, President of Karen Zupko & Associate
- Novan Secures $50 Million Private Financinghttps://practicaldermatology.com/news/novan-secures-50-million-private-financing/2458973/Novan Therapeutics, a clinical-stage biotechnology company focused on advancing innovation in dermatology via nitric oxide therapies, today announced that it has secured $50 million in an oversubscribed private financing. New investor Malin Corporation Plc. (MLC: ISE) functioned as the cornerston
- MDRejuvena Launches Novel Product Line Focused on Skin Healthhttps://practicaldermatology.com/news/mdrejuvena-launches-novel-product-line-focused-on-skin-health/2458978/MDRejuvena, Inc. launched its novel, proprietary product line at the American Academy of Dermatology Meeting in San Francisco. MDRejuvena's product line, designed to rejuvenate, enhance, and maintain skin health, incorporates Phytochromatic MDT Complex, a proprietary, patented, plant-derived
- Nextech Systems and Iagnosis Showcase New Partnershiphttps://practicaldermatology.com/news/nextech-systems-and-iagnosis-showcase-new-partnership/2458982/Nextech, a leading provider of specialty-focused healthcare technology solutions for physician practices, announced an exclusive partnership with Iagnosis, a leading telemedicine provider of online dermatology solutions. Iagnosis provides a teledermatolog
- Suneva Medical Introduces Regenica Recovery Gelhttps://practicaldermatology.com/news/suneva-medical-introduces-regenica-recovery-gel/2458983/Suneva Medical, Inc. introduced Regenica® Recovery Gel, a new addition to the Regenica® skin care system, during the American Academy of Dermatology Annual Meeting. Regenica® Recovery Gel is a soothing balm that is specially formulated to help quickly heal damaged skin. It infuses Mul
- Alma Lasers Releases Soprano ICE Multi-Platform Hair Removal System with Alex™ Technologyhttps://practicaldermatology.com/news/alma-lasers-releases-soprano-ice-multi-platform-hair-removal-system-with-alex-technology/2458984/Alma Lasers added the Soprano ICE ™ platform to its product portfolio. The Soprano ICE Multi-Platform combines the high absorption benefits of the Alexandrite (755nm) wavelength with the advantages of a diode laser providing more comfort for the patient during hair removal and lower mainten
- Syneron Candela Launches "Changing Lives" Program At AADhttps://practicaldermatology.com/news/syneron-candela-launches-changing-lives-program-at-aad/2458985/Syneron Medical Ltd. is introducing the Changing Lives Program, a corporate wide initiative that the company says leverages its life-changing technologies with life-changing causes. Launching at the annual American Academy of Dermatology (AAD) meeting in San Francisco on March 21, Changing Lives&
- Alma Lasers Introduces Harmony XL Pro Multi-Application Platformhttps://practicaldermatology.com/news/alma-lasers-introduces-harmony-xl-pro-multi-application-platform/2458987/Alma Lasers introduced the Harmony XL Pro™ platform to its product portfolio. The platform will be presented at the American Academy of Dermatology Meeting in San Francisco, CA from March 21 - 23 at Booth 2428. The Harmony XL Pro platform consists of multiple modules offering powerf
- Aclaris Therapeutics' A-101 Achieves Positive Results in Clinical Trial for Seborrheic Keratosishttps://practicaldermatology.com/news/aclaris-therapeutics-a-101-achieves-positive-results-in-clinical-trial-for-seborrheic-keratosis/2458989/Aclaris Therapeutics, Inc.’s lead drug candidate A-10 demonstrated clinically and statistically significant improvements in removing seborrheic keratosis (SK) lesions on the face in its third Phase II clinical trial. The double-blind, vehicle-controlled Phase 2 clinical trial was designed t